influenza virus infection vaccine (Novavax)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinfluenza virus infection vaccine (Novavax)
Drug Alias Nameinfluenza vaccine (Laboratorios Farmaceuticos Rovi)influenza virus infection vaccine (Laboratorios Farmaceuticos Rovi)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratorios Farmacéuticos Rovi SaNovavax Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A